Imunon Inc. (IMNN) Financial Statements (2024 and earlier)

Company Profile

Business Address 997 LENOX DRIVE
LAWRENCEVILLE, NJ 08648
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:32,80056,90017,16414,81827,58224,200
Cash and cash equivalents11,49319,58617,1646,87513,35411,444
Short-term investments21,22829,811 7,94314,22812,724
Other undisclosed cash, cash equivalents, and short-term investments797,503   32
Receivables2,7782,4471,6611,35345189
Debt securities, held-to-maturity, accrued interest, after allowance for credit loss 129  
Other undisclosed current assets1,447(7,402) 649823
Total current assets:37,15551,94618,82516,23528,13124,312
Noncurrent Assets
Operating lease, right-of-use asset    1,432
Property, plant and equipment548477295   
Intangible assets, net (including goodwill)    18,05418,28123,018
Goodwill    1,9761,9761,976
Intangible assets, net (excluding goodwill)    16,07716,30521,042
Deposits noncurrent assets    333259 
Deferred income tax assets    1,819
Other noncurrent assets6,27321,62418,408  9
Total noncurrent assets:6,82122,10118,70221,63818,54023,027
Other undisclosed assets    405185176
TOTAL ASSETS:43,97674,04737,52738,27846,85647,514
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,3825,7214,7035,1665,6075,700
Accounts payable3,5872,5472,2452,8633,0213,417
Accrued liabilities4,7953,1742,4592,3042,5862,283
Deferred revenue  500500500
Debt 1,425 1,1172,228  
Deferred revenue and credits500
Contract with customer, liability500
Other undisclosed current liabilities231549433   
Total current liabilities:10,0376,7706,7537,8946,1076,200
Noncurrent Liabilities
Long-term debt and lease obligation 4,6116,0854,6459,1079,417 
Long-term debt, excluding current maturities 4,6115,8543,9347,9639,417 
Liabilities, other than long-term debt 5,3967,5186,7188,97114,610
Deferred revenue and credits2,000
Deferred revenue   5001,000
Other liabilities     6372
Operating lease, liability 2317101,144
Business combination, contingent consideration, liability  5,3967,0185,7188,90812,539
Other undisclosed noncurrent liabilities     1,500 
Total noncurrent liabilities:4,61111,48112,16315,82519,88814,610
Total liabilities:14,64818,25118,91623,71925,99520,810
Equity
Equity, attributable to parent29,32855,79618,61114,55920,86126,705
Common stock7458407233188173
Treasury stock, value(85)(85)(85)(85)(85)(85)
Additional paid in capital397,980388,601330,290304,886294,393288,409
Accumulated other comprehensive income (loss)26(8) 4330(10)
Accumulated deficit(368,668)(332,770)(312,000)(290,517)(273,665)(261,782)
Total equity:29,32855,79618,61114,55920,86126,705
TOTAL LIABILITIES AND EQUITY:43,97674,04737,52738,27846,85647,514

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues 500500500500500500
Revenue, net500
Gross profit: 500500500500500500
Operating expenses(25,422)(21,507)(18,986)(21,065)(21,565)(18,968)
Other undisclosed operating income      
Operating loss:(24,922)(21,007)(18,486)(20,565)(21,065)(18,468)
Nonoperating income (expense)(12,544)(1,146)(4,843)1,897(1,237)(1,934)
Investment income, nonoperating4531112050135426
Interest and debt expense(5,029)(234)(1,292)(1,393)(712)(92)
Loss from continuing operations before equity method investments, income taxes:(42,494)(22,387)(24,622)(20,061)(23,014)(20,494)
Other undisclosed income from continuing operations before income taxes5,0292341,2921,393712 
Loss from continuing operations before income taxes:(37,465)(22,153)(23,329)(18,668)(22,302)(20,494)
Income tax benefit1,5671,3831,8461,81610,419 
Loss from continuing operations:(35,898)(20,769)(21,484)(16,852)(11,883)(20,494)
Loss before gain (loss) on sale of properties:(20,769)(21,484)(16,852)(11,883)(20,494)
Net loss:(35,898)(20,769)(21,484)(16,852)(11,883)(20,494)
Other undisclosed net income attributable to parent      92
Net loss attributable to parent:(35,898)(20,769)(21,484)(16,852)(11,883)(20,402)
Other undisclosed net loss available to common stockholders, basic      (346)
Net loss available to common stockholders, diluted:(35,898)(20,769)(21,484)(16,852)(11,883)(20,748)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(35,898)(20,769)(21,484)(16,852)(11,883)(20,494)
Comprehensive loss:(35,898)(20,769)(21,484)(16,852)(11,883)(20,494)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent268(43)134082
Comprehensive loss, net of tax, attributable to parent:(35,872)(20,761)(21,526)(16,839)(11,843)(20,412)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: